Seth Harmon
Chief Financial OfficerMr. Seth Harmon serves as it's Chief Financial Officer at Viridian Therapeutics, Inc. since January 1, 2025 and had been Senior Vice President of Finance and Accounting since May 2023 until January 2025 and serves as it's Principal Financial & Accounting Officer since September 12, 2023 also Joined Viridian Therapeutics, Inc also. On May 2023. He served as Vice President of Finance and Administration and Chief Financial Officer at BioNTech US Inc. since July 2020 until May 2023. He has of experience working in finance and operations. Prior to BioNTech, he held a variety of positions at Neon Therapeutics, including Controller and VP of Finance and Accounting. Prior to his role at BioNTech US Inc., he was the Corporate Controller at Merrimack Pharmaceuticals Inc. Seth Harmon holds a B.A. in Economics and Mathematics from Bowdoin College and a M.B.A and M.S. in Accounting from Northeastern University and obtained his certified public accountant license while working at Ernst and Young, LLP.
Positions
- Company NameViridian Therapeutics, Inc.Stock CodeVRDNPositionChief Financial OfficerColleagues
- SFStephen F. MahoneyCEO, President & Director
- TKTomas KiselakIndependent Chairperson of Board
- TWThomas W. BeethamChief Operating Officer
- JTJennifer TousignantChief Legal Officer & Corporate Secretary
- RTRadhika TripuraneniChief Medical Officer
- ENEric N. OlsonCo-Founder & Chairman of Scientific Advisory Board
- MRMichael R. BristowCo-Founder & Member of the Scientific Advisory Board
- MHMarvin H. CaruthersCo-Founder & Scientific Advisory Board Member
